Tuesday, March 28, 2023
HomeGeorgia & USAArtivion: Shot of earnings for the 4th quarter State News

Artivion: Shot of earnings for the 4th quarter State News

KENNESAW, Georgia (AP) – Artivion, Inc. (AORT) on Thursday reported a loss of $ 20.1 million in the fourth quarter.

The company, based in Kennesaw, Georgia, said the loss was 51 cents. Earnings adjusted for one-time expenses and depreciation expenses were less than 1 cent per share.

During this period, the manufacturer of biological medical devices received $ 79.4 million.

For the year, the company said its losses fell to $ 14.8 million, or 38 cents a share. Revenue was $ 298.8 million.

Artivion expects year-over-year profits in the range of $ 319 million to $ 325 million.

Since the beginning of the year, Artivion shares have fallen by 14%. In the last minutes of trading on Thursday, the stock reached $ 17.50, down 30% over the past 12 months.

—————

This story spawned Automated information (http://automatedinsights.com/ap) using Zacks Investment Research data. Access a Zacks stock report on AORT on https://www.zacks.com/ap/AORT

Copyright – Automated Insights, Inc. All rights reserved.

Reported by Source link

RELATED ARTICLES
- Advertisment -

Most Popular

Artivion: Shot of earnings for the 4th quarter State News

KENNESAW, Georgia (AP) – Artivion, Inc. (AORT) on Thursday reported a loss of $ 20.1 million in the fourth quarter.

The company, based in Kennesaw, Georgia, said the loss was 51 cents. Earnings adjusted for one-time expenses and depreciation expenses were less than 1 cent per share.

During this period, the manufacturer of biological medical devices received $ 79.4 million.

For the year, the company said its losses fell to $ 14.8 million, or 38 cents a share. Revenue was $ 298.8 million.

Artivion expects year-over-year profits in the range of $ 319 million to $ 325 million.

Since the beginning of the year, Artivion shares have fallen by 14%. In the last minutes of trading on Thursday, the stock reached $ 17.50, down 30% over the past 12 months.

—————

This story spawned Automated information (http://automatedinsights.com/ap) using Zacks Investment Research data. Access a Zacks stock report on AORT on https://www.zacks.com/ap/AORT

Copyright – Automated Insights, Inc. All rights reserved.

Reported by Source link

RELATED ARTICLES
- Advertisment -

Most Popular